These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 26304941)

  • 21. Reduced thrombin activatable fibrinolysis inhibitor and enhanced proinflammatory cytokines in acute coronary syndrome.
    Pang H; Zhang C; Liu F; Gong X; Jin X; Su C
    Med Intensiva; 2017 Nov; 41(8):475-482. PubMed ID: 28038785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of pro-/anti-inflammatory cytokines and their correlation with established risk factors in South Indians with coronary artery disease.
    Rajappa M; Sen SK; Sharma A
    Angiology; 2009; 60(4):419-26. PubMed ID: 18796448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colchicine Inhibits Neutrophil Extracellular Trap Formation in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention.
    Vaidya K; Tucker B; Kurup R; Khandkar C; Pandzic E; Barraclough J; Machet J; Misra A; Kavurma M; Martinez G; Rye KA; Cochran BJ; Patel S
    J Am Heart Assoc; 2021 Jan; 10(1):e018993. PubMed ID: 33346683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of Borago officinalis on the signaling pathway of the NLRP3 inflammasome complex, TLR4 and some inflammatory cytokines in type II diabetic patients with acute respiratory distress syndrome.
    Yue Y; Jin F; Yue X
    Cell Mol Biol (Noisy-le-grand); 2021 Nov; 67(3):178-183. PubMed ID: 34933712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical implication and association between local and systemic levels of interleukin-1β and interleukin-10 in patients with coronary artery disease].
    Yan HB; Li WZ; Zhao HJ; Song L; Zheng B; Zhou P; Liu C
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Feb; 39(2):142-6. PubMed ID: 21426749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID-TIMI 52 (Stabilization of Plaque Using Darapladib-Thrombolysis in Myocardial Infarction 52) Trial.
    Fanola CL; Morrow DA; Cannon CP; Jarolim P; Lukas MA; Bode C; Hochman JS; Goodrich EL; Braunwald E; O'Donoghue ML
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelets, inflammation and anti-inflammatory effects of antiplatelet drugs in ACS and CAD.
    Müller KA; Chatterjee M; Rath D; Geisler T
    Thromb Haemost; 2015 Aug; 114(3):498-518. PubMed ID: 26224127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-6 level is a powerful predictor of long-term cardiovascular mortality in patients with acute coronary syndrome.
    Gager GM; Biesinger B; Hofer F; Winter MP; Hengstenberg C; Jilma B; Eyileten C; Postula M; Lang IM; Siller-Matula JM
    Vascul Pharmacol; 2020 Dec; 135():106806. PubMed ID: 33035661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory and anti-inflammatory variable clusters and risk prediction in acute coronary syndrome patients: a factor analysis approach.
    Tziakas DN; Chalikias GK; Kaski JC; Kekes A; Hatzinikolaou EI; Stakos DA; Tentes IK; Kortsaris AX; Hatseras DI
    Atherosclerosis; 2007 Jul; 193(1):196-203. PubMed ID: 16857204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory cytokines imbalance in the very early phase of acute coronary syndrome: correlations with angiographic findings and in-hospital events.
    Brunetti ND; Munno I; Pellegrino PL; Ruggero V; Correale M; De Gennaro L; Cuculo A; Campanale EG; Di Biase M
    Inflammation; 2011 Feb; 34(1):58-66. PubMed ID: 20405189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serial changes in plasma levels of cytokines in patients with coronary artery disease.
    Heinisch RH; Zanetti CR; Comin F; Fernandes JL; Ramires JA; Serrano CV
    Vasc Health Risk Manag; 2005; 1(3):245-50. PubMed ID: 17319110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preprocedural statin therapy, inflammation, and myocardial injury in low-risk stable coronary artery disease patients submitted to coronary stent implantation.
    Greque GV; Serrano CV; Strunz CM; Soeiro A; Santos M; Pivateli F; Jacob JL; Pesaro AE; Nicolau JC; Kalil-Filho R
    Catheter Cardiovasc Interv; 2016 Feb; 87(2):222-9. PubMed ID: 23592528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation.
    Bonaventura A; Vecchié A; Dagna L; Tangianu F; Abbate A; Dentali F
    Inflamm Res; 2022 Mar; 71(3):293-307. PubMed ID: 35113170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass.
    Wan S; DeSmet JM; Barvais L; Goldstein M; Vincent JL; LeClerc JL
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):806-11. PubMed ID: 8800171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TH1/TH2 imbalance, measured by circulating and intracytoplasmic inflammatory cytokines--immunological alterations in acute coronary syndrome and stable coronary artery disease.
    Szodoray P; Timar O; Veres K; Der H; Szomjak E; Lakos G; Aleksza M; Nakken B; Szegedi G; Soltesz P
    Scand J Immunol; 2006 Sep; 64(3):336-44. PubMed ID: 16918703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different effects of perindopril and enalapril on monocyte cytokine release in coronary artery disease patients with normal blood pressure.
    Krysiak R; Okopień B
    Pharmacol Rep; 2012; 64(6):1466-75. PubMed ID: 23406757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory role and prognostic value of platelet chemokines in acute coronary syndrome.
    Blanchet X; Cesarek K; Brandt J; Herwald H; Teupser D; Küchenhoff H; Karshovska E; Mause SF; Siess W; Wasmuth H; Soehnlein O; Koenen RR; Weber C; von Hundelshausen P
    Thromb Haemost; 2014 Dec; 112(6):1277-87. PubMed ID: 25183015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time course changes of cystatin C and inflammatory and biochemical markers in non-ST-elevation acute coronary syndromes.
    De Servi S; Mariani G; Piatti L; Leoncini M; Rubartelli P; Pitì A; Curello S; Galdangelo F; Vandoni P; Rossetti E; Mariani M; Boschetti E; Re G; Loznicker M
    J Cardiovasc Med (Hagerstown); 2014 Jan; 15(1):42-7. PubMed ID: 24492354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imbalance of T-helper 1/T-helper 2 cytokines and impaired glucose tolerance among patient with acute coronary syndrome.
    Zhao SL; Mo ZH; He HH; Zhao LL; Xie YH
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S480-S485. PubMed ID: 29970710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time course of systemic markers of inflammation in patients presenting with acute coronary syndromes.
    Brueckmann M; Bertsch T; Lang S; Sueselbeck T; Wolpert C; Kaden JJ; Jaramillo C; Huhle G; Borggrefe M; Haase KK
    Clin Chem Lab Med; 2004; 42(10):1132-9. PubMed ID: 15552272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.